Salarius Pharmaceuticals, Inc. (SLRX) Financials

SLRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 8.4 million 2.3 million
2023-06-30 12.1 million 3.6 million
2023-03-31 10.1 million 4.5 million
2022-12-31 14.7 million 4.3 million

SLRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.7 million 112658
2023-06-30 -4.4 million 123459
2023-03-31 -3.2 million 203345
2022-12-31 -3.2 million 145507

SLRX Net Income

No data available :(

SLRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 7.6 million - -
2023-06-30 11.5 million - -
2023-03-31 9.3 million - -
2022-12-31 12.1 million - -

SLRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 3.8 million
2023-06-30 2.7 million
2023-03-31 2.4 million
2022-12-31 2.1 million

SLRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.0 million 1.5 million -
2023-06-30 - 2.4 million 1.6 million -
2023-03-31 - 3.7 million 1.7 million -
2022-12-31 1.5 million 4.7 million 1.8 million -

SLRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 5608
2023-06-30 - 1669
2023-03-31 - 1669
2022-12-31 - 1669

SLRX

Price: $0.48

52 week price:
0.43
2.68

Earnings Per Share: -3.84 USD

P/E Ratio: -0.09

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 285400

Market Capitalization: 1.9 million

Links: